- Home
- AYTU vs AMS Comparison
AYTU vs AMS Comparison
Compare AYTU & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- AMS
- Stock Information
- Founded
- AYTU N/A
- AMS 1980
- Country
- AYTU United States
- AMS United States
- Employees
- AYTU N/A
- AMS N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- AYTU Health Care
- AMS Health Care
- Exchange
- AYTU Nasdaq
- AMS Nasdaq
- Market Cap
- AYTU 19.7M
- AMS 17.2M
- IPO Year
- AYTU N/A
- AMS N/A
- Fundamental
- Price
- AYTU $2.20
- AMS $2.45
- Analyst Decision
- AYTU Strong Buy
- AMS
- Analyst Count
- AYTU 2
- AMS 0
- Target Price
- AYTU $10.00
- AMS N/A
- AVG Volume (30 Days)
- AYTU 109.6K
- AMS 4.0K
- Earning Date
- AYTU 09-25-2025
- AMS 08-13-2025
- Dividend Yield
- AYTU N/A
- AMS N/A
- EPS Growth
- AYTU N/A
- AMS N/A
- EPS
- AYTU N/A
- AMS N/A
- Revenue
- AYTU $81,659,000.00
- AMS $29,251,000.00
- Revenue This Year
- AYTU N/A
- AMS $5.06
- Revenue Next Year
- AYTU $1.05
- AMS N/A
- P/E Ratio
- AYTU N/A
- AMS N/A
- Revenue Growth
- AYTU 0.41
- AMS 26.61
- 52 Week Low
- AYTU $0.95
- AMS $2.27
- 52 Week High
- AYTU $2.85
- AMS $4.60
- Technical
- Relative Strength Index (RSI)
- AYTU 43.54
- AMS 45.80
- Support Level
- AYTU $2.15
- AMS $2.40
- Resistance Level
- AYTU $2.28
- AMS $2.70
- Average True Range (ATR)
- AYTU 0.11
- AMS 0.10
- MACD
- AYTU -0.03
- AMS -0.02
- Stochastic Oscillator
- AYTU 16.07
- AMS 17.35
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.